IMS Capital Management Invests $482,000 in UnitedHealth Group Inc (NYSE:UNH)

IMS Capital Management purchased a new position in shares of UnitedHealth Group Inc (NYSE:UNH) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 2,219 shares of the healthcare conglomerate’s stock, valued at approximately $482,000.

Several other institutional investors and hedge funds have also modified their holdings of UNH. Garrison Point Advisors LLC increased its stake in shares of UnitedHealth Group by 1.2% during the second quarter. Garrison Point Advisors LLC now owns 3,486 shares of the healthcare conglomerate’s stock worth $851,000 after buying an additional 40 shares during the period. Smith Moore & CO. increased its stake in shares of UnitedHealth Group by 1.3% during the second quarter. Smith Moore & CO. now owns 3,156 shares of the healthcare conglomerate’s stock worth $770,000 after buying an additional 41 shares during the period. Integrated Investment Consultants LLC increased its stake in shares of UnitedHealth Group by 3.9% during the second quarter. Integrated Investment Consultants LLC now owns 1,131 shares of the healthcare conglomerate’s stock worth $276,000 after buying an additional 42 shares during the period. Meridian Financial Partners LLC increased its stake in shares of UnitedHealth Group by 2.7% during the second quarter. Meridian Financial Partners LLC now owns 1,633 shares of the healthcare conglomerate’s stock worth $403,000 after buying an additional 43 shares during the period. Finally, 1ST Source Bank increased its stake in shares of UnitedHealth Group by 3.0% during the second quarter. 1ST Source Bank now owns 1,569 shares of the healthcare conglomerate’s stock worth $383,000 after buying an additional 45 shares during the period. 85.66% of the stock is currently owned by institutional investors and hedge funds.

UNH has been the topic of a number of recent research reports. Cantor Fitzgerald set a $310.00 target price on shares of UnitedHealth Group and gave the stock a “buy” rating in a research note on Friday, July 19th. Cleveland Research restated a “buy” rating on shares of UnitedHealth Group in a research note on Monday, July 15th. Zacks Investment Research upgraded shares of UnitedHealth Group from a “sell” rating to a “buy” rating and set a $269.00 target price on the stock in a research note on Monday, July 22nd. Credit Suisse Group set a $293.00 target price on shares of UnitedHealth Group and gave the stock a “buy” rating in a research note on Thursday, August 29th. Finally, Royal Bank of Canada set a $311.00 target price on shares of UnitedHealth Group and gave the stock a “buy” rating in a research note on Friday, July 19th. Four research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. UnitedHealth Group currently has a consensus rating of “Buy” and an average price target of $286.65.



In other news, Director Timothy Patrick Flynn acquired 2,000 shares of the firm’s stock in a transaction dated Wednesday, August 28th. The stock was acquired at an average cost of $227.55 per share, with a total value of $455,100.00. Following the completion of the acquisition, the director now owns 5,524 shares of the company’s stock, valued at $1,256,986.20. The acquisition was disclosed in a legal filing with the SEC, which is available through this link. Also, Director William C. Ballard, Jr. sold 12,000 shares of the stock in a transaction that occurred on Tuesday, July 23rd. The shares were sold at an average price of $255.31, for a total value of $3,063,720.00. Following the completion of the sale, the director now directly owns 61,309 shares of the company’s stock, valued at $15,652,800.79. The disclosure for this sale can be found here. Insiders sold 24,000 shares of company stock worth $5,924,120 over the last quarter. 0.82% of the stock is currently owned by insiders.

UnitedHealth Group stock traded up $1.97 during mid-day trading on Wednesday, hitting $222.08. The company had a trading volume of 4,143,866 shares, compared to its average volume of 4,550,181. The stock has a market cap of $208.30 billion, a price-to-earnings ratio of 17.24, a PEG ratio of 1.17 and a beta of 0.60. UnitedHealth Group Inc has a 1 year low of $208.07 and a 1 year high of $287.94. The company has a quick ratio of 0.67, a current ratio of 0.67 and a debt-to-equity ratio of 0.62. The business has a fifty day moving average of $227.85 and a 200 day moving average of $240.32.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Thursday, July 18th. The healthcare conglomerate reported $3.60 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $3.46 by $0.14. The company had revenue of $60.60 billion for the quarter, compared to analyst estimates of $60.59 billion. UnitedHealth Group had a net margin of 5.51% and a return on equity of 25.20%. The firm’s revenue was up 8.0% on a year-over-year basis. During the same period in the prior year, the firm posted $3.14 earnings per share. Equities analysts anticipate that UnitedHealth Group Inc will post 14.83 earnings per share for the current year.

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th were paid a $1.08 dividend. The ex-dividend date of this dividend was Friday, September 13th. This represents a $4.32 annualized dividend and a yield of 1.95%. UnitedHealth Group’s dividend payout ratio is currently 33.54%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Featured Story: How to execute a trade ex-dividend strategy?

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.